Safilens has announced the publication in the Journal Ophthalmology and Therapy a peer-reviewed article titled, ‘Post-market surveillance analysis of refractive data in users of Delivery Tyro, a tyrosine-releasing contact lens‘.
The article presents the results of an analysis conducted on 241 young myopic individuals (average age: 14.7 years) who used Delivery Tyro daily disposable contact lenses for a 12-month period.
The study was carried out in collaboration with the Advanced Contact Lens Research Center at the University of Salento and the Veneto Eye Bank Foundation.
The results show that after one year of use, the average myopic progression was -0.04D, compared to an expected value of -0.28D, according to a meta-analysis of reference data.
Ninety-four per cent of the eyes examined showed no significant changes in refraction (≤ -0.25D), with an 85 per cent reduction in myopia progression compared to expected values. These data were collected as part of a post-market surveillance programme involving 55 optometrists across Italy.
Delivery Tyro is the first daily contact lens with controlled release of tyrosine, a precursor of dopamine – a key neurotransmitter involved in regulating eye growth. The lenses also incorporate hyaluronic acid and TSP, enhancing comfort and tear film stability.
“The study results provide initial clinical confirmation of the potential of Delivery Tyro as a practical and effective option for myopia control, offering users the highest possible visual acuity without compromise or risk,” said Daniele Bazzocchi, co-author of the article and general manager of Safilens.
Image from stock.